CN105617007A - Traditional Chinese medicine for treating tumors and preparation method of traditional Chinese medicine - Google Patents
Traditional Chinese medicine for treating tumors and preparation method of traditional Chinese medicine Download PDFInfo
- Publication number
- CN105617007A CN105617007A CN201610183374.0A CN201610183374A CN105617007A CN 105617007 A CN105617007 A CN 105617007A CN 201610183374 A CN201610183374 A CN 201610183374A CN 105617007 A CN105617007 A CN 105617007A
- Authority
- CN
- China
- Prior art keywords
- parts
- chinese medicine
- weight
- animal
- raw material
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000003814 drug Substances 0.000 title claims abstract description 95
- 206010028980 Neoplasm Diseases 0.000 title claims abstract description 52
- 238000002360 preparation method Methods 0.000 title claims abstract description 11
- 241001465754 Metazoa Species 0.000 claims abstract description 51
- 241000196324 Embryophyta Species 0.000 claims abstract description 37
- 239000002994 raw material Substances 0.000 claims abstract description 31
- 241000258920 Chilopoda Species 0.000 claims abstract description 13
- 244000144730 Amygdalus persica Species 0.000 claims abstract description 5
- 235000006040 Prunus persica var persica Nutrition 0.000 claims abstract description 5
- 239000000463 material Substances 0.000 claims description 77
- 239000000203 mixture Substances 0.000 claims description 20
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 17
- 239000000284 extract Substances 0.000 claims description 16
- 238000011282 treatment Methods 0.000 claims description 16
- 241000361919 Metaphire sieboldi Species 0.000 claims description 13
- 238000009835 boiling Methods 0.000 claims description 7
- 239000012530 fluid Substances 0.000 claims description 7
- 239000007788 liquid Substances 0.000 claims description 7
- 239000002245 particle Substances 0.000 claims description 7
- 230000001954 sterilising effect Effects 0.000 claims description 7
- 240000006509 Gynostemma pentaphyllum Species 0.000 claims description 3
- 235000002956 Gynostemma pentaphyllum Nutrition 0.000 claims description 3
- 244000167230 Lonicera japonica Species 0.000 claims description 3
- 235000017617 Lonicera japonica Nutrition 0.000 claims description 3
- 210000004881 tumor cell Anatomy 0.000 abstract description 7
- 229940079593 drug Drugs 0.000 abstract description 6
- 244000153955 Reynoutria sachalinensis Species 0.000 abstract description 3
- 235000003202 Reynoutria sachalinensis Nutrition 0.000 abstract description 3
- 230000008901 benefit Effects 0.000 abstract description 3
- 210000001185 bone marrow Anatomy 0.000 abstract description 3
- 230000002401 inhibitory effect Effects 0.000 abstract description 3
- 235000011201 Ginkgo Nutrition 0.000 abstract description 2
- 244000194101 Ginkgo biloba Species 0.000 abstract description 2
- 235000008100 Ginkgo biloba Nutrition 0.000 abstract description 2
- 230000036039 immunity Effects 0.000 abstract description 2
- 230000000242 pagocytic effect Effects 0.000 abstract description 2
- 241000227129 Aconitum Species 0.000 abstract 1
- 241000205585 Aquilegia canadensis Species 0.000 abstract 1
- 244000248539 Asparagus cochinchinensis Species 0.000 abstract 1
- 235000009292 Asparagus cochinchinensis Nutrition 0.000 abstract 1
- 241000045403 Astragalus propinquus Species 0.000 abstract 1
- 241000846172 Cremastra appendiculata Species 0.000 abstract 1
- 241001632410 Eleutherococcus senticosus Species 0.000 abstract 1
- 241001125591 Eremogone brevipetala Species 0.000 abstract 1
- 240000005779 Jasminum multiflorum Species 0.000 abstract 1
- 244000003187 Juncus effusus Species 0.000 abstract 1
- 241000243684 Lumbricus Species 0.000 abstract 1
- 244000179560 Prunella vulgaris Species 0.000 abstract 1
- 208000032023 Signs and Symptoms Diseases 0.000 abstract 1
- 241000157373 Uncaria rhynchophylla Species 0.000 abstract 1
- 235000006533 astragalus Nutrition 0.000 abstract 1
- 230000003394 haemopoietic effect Effects 0.000 abstract 1
- 210000000265 leukocyte Anatomy 0.000 abstract 1
- 210000002540 macrophage Anatomy 0.000 abstract 1
- 235000008113 selfheal Nutrition 0.000 abstract 1
- 210000000582 semen Anatomy 0.000 abstract 1
- 230000004614 tumor growth Effects 0.000 abstract 1
- 230000000694 effects Effects 0.000 description 15
- 239000008280 blood Substances 0.000 description 13
- 210000004369 blood Anatomy 0.000 description 13
- 210000004185 liver Anatomy 0.000 description 13
- 235000009508 confectionery Nutrition 0.000 description 12
- 235000019640 taste Nutrition 0.000 description 8
- 238000012360 testing method Methods 0.000 description 8
- 241000699666 Mus <mouse, genus> Species 0.000 description 7
- 230000000259 anti-tumor effect Effects 0.000 description 7
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 7
- 210000003734 kidney Anatomy 0.000 description 7
- 229940041181 antineoplastic drug Drugs 0.000 description 6
- 230000007812 deficiency Effects 0.000 description 6
- 201000010099 disease Diseases 0.000 description 6
- 208000002193 Pain Diseases 0.000 description 5
- 229920002472 Starch Polymers 0.000 description 5
- 239000002246 antineoplastic agent Substances 0.000 description 5
- 210000000988 bone and bone Anatomy 0.000 description 5
- 210000004072 lung Anatomy 0.000 description 5
- 210000003205 muscle Anatomy 0.000 description 5
- 230000036407 pain Effects 0.000 description 5
- 239000008107 starch Substances 0.000 description 5
- 235000019698 starch Nutrition 0.000 description 5
- 230000008961 swelling Effects 0.000 description 5
- 208000006820 Arthralgia Diseases 0.000 description 4
- 206010011224 Cough Diseases 0.000 description 4
- 230000017531 blood circulation Effects 0.000 description 4
- 230000037396 body weight Effects 0.000 description 4
- 239000002775 capsule Substances 0.000 description 4
- 238000002512 chemotherapy Methods 0.000 description 4
- 238000000034 method Methods 0.000 description 4
- 231100000252 nontoxic Toxicity 0.000 description 4
- 230000003000 nontoxic effect Effects 0.000 description 4
- 206010007247 Carbuncle Diseases 0.000 description 3
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 3
- 206010039491 Sarcoma Diseases 0.000 description 3
- 208000027418 Wounds and injury Diseases 0.000 description 3
- 201000011510 cancer Diseases 0.000 description 3
- 210000004027 cell Anatomy 0.000 description 3
- 208000002173 dizziness Diseases 0.000 description 3
- 230000002496 gastric effect Effects 0.000 description 3
- 241000411851 herbal medicine Species 0.000 description 3
- 238000001802 infusion Methods 0.000 description 3
- 230000005764 inhibitory process Effects 0.000 description 3
- 239000013641 positive control Substances 0.000 description 3
- 210000000952 spleen Anatomy 0.000 description 3
- 230000004083 survival effect Effects 0.000 description 3
- AZAZKLKDEOMJBJ-AFJRDBIPSA-N 6ppc7ud22e Chemical compound O[C@H]([C@@H]1C[C@@]23[C@@H](C1=C)O)C[C@H]2[C@]12[C@@H](O)CC[C@@]4(C)CN(CC)[C@@H]2[C@@H]3C[C@H]41 AZAZKLKDEOMJBJ-AFJRDBIPSA-N 0.000 description 2
- 241000110637 Cuscuta chinensis Species 0.000 description 2
- 229920001353 Dextrin Polymers 0.000 description 2
- 239000004375 Dextrin Substances 0.000 description 2
- 206010062717 Increased upper airway secretion Diseases 0.000 description 2
- 206010023126 Jaundice Diseases 0.000 description 2
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 2
- 208000000112 Myalgia Diseases 0.000 description 2
- AZAZKLKDEOMJBJ-UHFFFAOYSA-N Napellin-N-oxid Natural products C=C1C(O)C23CC1C(O)CC2C12C(O)CCC4(C)CN(CC)C2C3CC41 AZAZKLKDEOMJBJ-UHFFFAOYSA-N 0.000 description 2
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 2
- 229930006000 Sucrose Natural products 0.000 description 2
- 208000025865 Ulcer Diseases 0.000 description 2
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 description 2
- 206010052428 Wound Diseases 0.000 description 2
- 230000001154 acute effect Effects 0.000 description 2
- 230000000202 analgesic effect Effects 0.000 description 2
- 238000010171 animal model Methods 0.000 description 2
- 230000001754 anti-pyretic effect Effects 0.000 description 2
- 210000001367 artery Anatomy 0.000 description 2
- 230000036772 blood pressure Effects 0.000 description 2
- 239000001913 cellulose Substances 0.000 description 2
- 229920002678 cellulose Polymers 0.000 description 2
- 239000003795 chemical substances by application Substances 0.000 description 2
- 238000001816 cooling Methods 0.000 description 2
- 230000006378 damage Effects 0.000 description 2
- 230000034994 death Effects 0.000 description 2
- 238000013461 design Methods 0.000 description 2
- 235000019425 dextrin Nutrition 0.000 description 2
- 208000001848 dysentery Diseases 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 2
- 230000003203 everyday effect Effects 0.000 description 2
- 238000002474 experimental method Methods 0.000 description 2
- 239000000796 flavoring agent Substances 0.000 description 2
- 235000019634 flavors Nutrition 0.000 description 2
- 230000012010 growth Effects 0.000 description 2
- 210000002216 heart Anatomy 0.000 description 2
- 208000035861 hematochezia Diseases 0.000 description 2
- 230000002607 hemopoietic effect Effects 0.000 description 2
- 230000023597 hemostasis Effects 0.000 description 2
- 230000006872 improvement Effects 0.000 description 2
- 208000015181 infectious disease Diseases 0.000 description 2
- 239000008101 lactose Substances 0.000 description 2
- 208000037841 lung tumor Diseases 0.000 description 2
- 230000027939 micturition Effects 0.000 description 2
- BQJCRHHNABKAKU-KBQPJGBKSA-N morphine Chemical compound O([C@H]1[C@H](C=C[C@H]23)O)C4=C5[C@@]12CCN(C)[C@@H]3CC5=CC=C4O BQJCRHHNABKAKU-KBQPJGBKSA-N 0.000 description 2
- IZUTYRYPLISYDD-UHFFFAOYSA-N napelline Natural products CCN1CC2(C)CCC(O)C34C5CC(O)C6CC5(CC(C13)C24)C(O)C6=C IZUTYRYPLISYDD-UHFFFAOYSA-N 0.000 description 2
- 239000013642 negative control Substances 0.000 description 2
- 231100000862 numbness Toxicity 0.000 description 2
- 230000001717 pathogenic effect Effects 0.000 description 2
- 208000026435 phlegm Diseases 0.000 description 2
- 229920000036 polyvinylpyrrolidone Polymers 0.000 description 2
- 235000013855 polyvinylpyrrolidone Nutrition 0.000 description 2
- 230000001737 promoting effect Effects 0.000 description 2
- QELSKZZBTMNZEB-UHFFFAOYSA-N propylparaben Chemical compound CCCOC(=O)C1=CC=C(O)C=C1 QELSKZZBTMNZEB-UHFFFAOYSA-N 0.000 description 2
- 230000001047 pyretic effect Effects 0.000 description 2
- 238000001959 radiotherapy Methods 0.000 description 2
- 238000011160 research Methods 0.000 description 2
- 238000012827 research and development Methods 0.000 description 2
- 230000000452 restraining effect Effects 0.000 description 2
- 210000002784 stomach Anatomy 0.000 description 2
- 238000005728 strengthening Methods 0.000 description 2
- 239000005720 sucrose Substances 0.000 description 2
- 208000024891 symptom Diseases 0.000 description 2
- 230000035922 thirst Effects 0.000 description 2
- 231100000331 toxic Toxicity 0.000 description 2
- 230000002588 toxic effect Effects 0.000 description 2
- 201000008827 tuberculosis Diseases 0.000 description 2
- 231100000397 ulcer Toxicity 0.000 description 2
- 230000024883 vasodilation Effects 0.000 description 2
- 210000003462 vein Anatomy 0.000 description 2
- MEIRRNXMZYDVDW-MQQKCMAXSA-N (2E,4E)-2,4-hexadien-1-ol Chemical compound C\C=C\C=C\CO MEIRRNXMZYDVDW-MQQKCMAXSA-N 0.000 description 1
- RIPYIJVYDYCPKW-UHFFFAOYSA-N 3-Acetylaconitine Natural products CCN1CC(C(CC2OC)OC(C)=O)(COC)C3C(OC)C(C(C45)(OC(C)=O)C(O)C6OC)C1C32C4CC6(O)C5OC(=O)C1=CC=CC=C1 RIPYIJVYDYCPKW-UHFFFAOYSA-N 0.000 description 1
- 206010000060 Abdominal distension Diseases 0.000 description 1
- 206010000087 Abdominal pain upper Diseases 0.000 description 1
- 208000010507 Adenocarcinoma of Lung Diseases 0.000 description 1
- GUBGYTABKSRVRQ-XLOQQCSPSA-N Alpha-Lactose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@H](O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-XLOQQCSPSA-N 0.000 description 1
- 235000015363 Amaranthus cruentus Nutrition 0.000 description 1
- 235000011746 Amaranthus hypochondriacus Nutrition 0.000 description 1
- 206010002368 Anger Diseases 0.000 description 1
- 241000432767 Asparagus setaceus Species 0.000 description 1
- 208000004429 Bacillary Dysentery Diseases 0.000 description 1
- 208000008035 Back Pain Diseases 0.000 description 1
- JMGZEFIQIZZSBH-UHFFFAOYSA-N Bioquercetin Natural products CC1OC(OCC(O)C2OC(OC3=C(Oc4cc(O)cc(O)c4C3=O)c5ccc(O)c(O)c5)C(O)C2O)C(O)C(O)C1O JMGZEFIQIZZSBH-UHFFFAOYSA-N 0.000 description 1
- 206010006187 Breast cancer Diseases 0.000 description 1
- 208000026310 Breast neoplasm Diseases 0.000 description 1
- 229920002134 Carboxymethyl cellulose Polymers 0.000 description 1
- 208000017897 Carcinoma of esophagus Diseases 0.000 description 1
- 206010008342 Cervix carcinoma Diseases 0.000 description 1
- 208000017667 Chronic Disease Diseases 0.000 description 1
- 206010010144 Completed suicide Diseases 0.000 description 1
- 206010010774 Constipation Diseases 0.000 description 1
- FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 description 1
- 206010011878 Deafness Diseases 0.000 description 1
- 201000004624 Dermatitis Diseases 0.000 description 1
- 206010012735 Diarrhoea Diseases 0.000 description 1
- 206010013789 Dry throat Diseases 0.000 description 1
- 206010014080 Ecchymosis Diseases 0.000 description 1
- 208000007530 Essential hypertension Diseases 0.000 description 1
- JOYRKODLDBILNP-UHFFFAOYSA-N Ethyl urethane Chemical compound CCOC(N)=O JOYRKODLDBILNP-UHFFFAOYSA-N 0.000 description 1
- 229930091371 Fructose Natural products 0.000 description 1
- 239000005715 Fructose Substances 0.000 description 1
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 description 1
- 206010017915 Gastroenteritis shigella Diseases 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- 208000008899 Habitual abortion Diseases 0.000 description 1
- 206010019233 Headaches Diseases 0.000 description 1
- 208000000616 Hemoptysis Diseases 0.000 description 1
- 208000032843 Hemorrhage Diseases 0.000 description 1
- 229920002153 Hydroxypropyl cellulose Polymers 0.000 description 1
- 206010020772 Hypertension Diseases 0.000 description 1
- 208000004044 Hypesthesia Diseases 0.000 description 1
- ZSBXGIUJOOQZMP-UHFFFAOYSA-N Isomatrine Natural products C1CCC2CN3C(=O)CCCC3C3C2N1CCC3 ZSBXGIUJOOQZMP-UHFFFAOYSA-N 0.000 description 1
- 206010024229 Leprosy Diseases 0.000 description 1
- 208000008930 Low Back Pain Diseases 0.000 description 1
- 206010058467 Lung neoplasm malignant Diseases 0.000 description 1
- 229930195725 Mannitol Natural products 0.000 description 1
- ZSBXGIUJOOQZMP-JLNYLFASSA-N Matrine Chemical compound C1CC[C@H]2CN3C(=O)CCC[C@@H]3[C@@H]3[C@H]2N1CCC3 ZSBXGIUJOOQZMP-JLNYLFASSA-N 0.000 description 1
- 206010027514 Metrorrhagia Diseases 0.000 description 1
- 241000699670 Mus sp. Species 0.000 description 1
- 206010030155 Oesophageal carcinoma Diseases 0.000 description 1
- 240000008663 Persicaria orientalis Species 0.000 description 1
- 201000005702 Pertussis Diseases 0.000 description 1
- 108091000080 Phosphotransferase Proteins 0.000 description 1
- 241001250596 Pleione Species 0.000 description 1
- 208000004880 Polyuria Diseases 0.000 description 1
- 208000012287 Prolapse Diseases 0.000 description 1
- 208000003251 Pruritus Diseases 0.000 description 1
- 208000008350 Pruritus Vulvae Diseases 0.000 description 1
- QNVSXXGDAPORNA-UHFFFAOYSA-N Resveratrol Natural products OC1=CC=CC(C=CC=2C=C(O)C(O)=CC=2)=C1 QNVSXXGDAPORNA-UHFFFAOYSA-N 0.000 description 1
- -1 Resveratrol glucoside Chemical class 0.000 description 1
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 1
- 208000005392 Spasm Diseases 0.000 description 1
- 235000021355 Stearic acid Nutrition 0.000 description 1
- UEDUENGHJMELGK-HYDKPPNVSA-N Stevioside Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1O[C@]12C(=C)C[C@@]3(C1)CC[C@@H]1[C@@](C)(CCC[C@]1([C@@H]3CC2)C)C(=O)O[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O UEDUENGHJMELGK-HYDKPPNVSA-N 0.000 description 1
- 208000005718 Stomach Neoplasms Diseases 0.000 description 1
- 108010023197 Streptokinase Proteins 0.000 description 1
- 206010053615 Thermal burn Diseases 0.000 description 1
- 208000009205 Tinnitus Diseases 0.000 description 1
- 241000983344 Trachelospermum jasminoides Species 0.000 description 1
- DWCSNWXARWMZTG-UHFFFAOYSA-N Trigonegenin A Natural products CC1C(C2(CCC3C4(C)CCC(O)C=C4CCC3C2C2)C)C2OC11CCC(C)CO1 DWCSNWXARWMZTG-UHFFFAOYSA-N 0.000 description 1
- 208000006105 Uterine Cervical Neoplasms Diseases 0.000 description 1
- 206010046788 Uterine haemorrhage Diseases 0.000 description 1
- 208000012886 Vertigo Diseases 0.000 description 1
- 206010047513 Vision blurred Diseases 0.000 description 1
- 206010056530 Vulvovaginal pruritus Diseases 0.000 description 1
- 206010047799 Vulvovaginitis trichomonal Diseases 0.000 description 1
- XQKRPEDJRVOOAA-UHFFFAOYSA-J [Mg+2].[Ca+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O Chemical compound [Mg+2].[Ca+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O XQKRPEDJRVOOAA-UHFFFAOYSA-J 0.000 description 1
- 210000001015 abdomen Anatomy 0.000 description 1
- 238000009825 accumulation Methods 0.000 description 1
- 230000007059 acute toxicity Effects 0.000 description 1
- 231100000403 acute toxicity Toxicity 0.000 description 1
- 238000009098 adjuvant therapy Methods 0.000 description 1
- 239000003513 alkali Substances 0.000 description 1
- 230000036592 analgesia Effects 0.000 description 1
- 208000022531 anorexia Diseases 0.000 description 1
- 230000001093 anti-cancer Effects 0.000 description 1
- 230000002929 anti-fatigue Effects 0.000 description 1
- 230000003110 anti-inflammatory effect Effects 0.000 description 1
- 230000001446 anti-myeloma Effects 0.000 description 1
- 230000000118 anti-neoplastic effect Effects 0.000 description 1
- 230000001663 anti-spastic effect Effects 0.000 description 1
- 239000002221 antipyretic Substances 0.000 description 1
- 210000000436 anus Anatomy 0.000 description 1
- 230000006907 apoptotic process Effects 0.000 description 1
- 238000013459 approach Methods 0.000 description 1
- 206010003246 arthritis Diseases 0.000 description 1
- 208000010668 atopic eczema Diseases 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
- 230000004071 biological effect Effects 0.000 description 1
- 230000033228 biological regulation Effects 0.000 description 1
- 235000019658 bitter taste Nutrition 0.000 description 1
- 230000000740 bleeding effect Effects 0.000 description 1
- 210000001124 body fluid Anatomy 0.000 description 1
- 239000010839 body fluid Substances 0.000 description 1
- CJZGTCYPCWQAJB-UHFFFAOYSA-L calcium stearate Chemical compound [Ca+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O CJZGTCYPCWQAJB-UHFFFAOYSA-L 0.000 description 1
- 239000008116 calcium stearate Substances 0.000 description 1
- 235000013539 calcium stearate Nutrition 0.000 description 1
- 239000004202 carbamide Substances 0.000 description 1
- 150000001719 carbohydrate derivatives Chemical class 0.000 description 1
- 239000001768 carboxy methyl cellulose Substances 0.000 description 1
- 235000010948 carboxy methyl cellulose Nutrition 0.000 description 1
- 125000002057 carboxymethyl group Chemical group [H]OC(=O)C([H])([H])[*] 0.000 description 1
- 239000008112 carboxymethyl-cellulose Substances 0.000 description 1
- 230000010261 cell growth Effects 0.000 description 1
- 230000004663 cell proliferation Effects 0.000 description 1
- 230000002490 cerebral effect Effects 0.000 description 1
- 201000010881 cervical cancer Diseases 0.000 description 1
- 239000012141 concentrate Substances 0.000 description 1
- 230000008602 contraction Effects 0.000 description 1
- 206010061428 decreased appetite Diseases 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 230000001627 detrimental effect Effects 0.000 description 1
- WQLVFSAGQJTQCK-VKROHFNGSA-N diosgenin Chemical compound O([C@@H]1[C@@H]([C@]2(CC[C@@H]3[C@@]4(C)CC[C@H](O)CC4=CC[C@H]3[C@@H]2C1)C)[C@@H]1C)[C@]11CC[C@@H](C)CO1 WQLVFSAGQJTQCK-VKROHFNGSA-N 0.000 description 1
- WQLVFSAGQJTQCK-UHFFFAOYSA-N diosgenin Natural products CC1C(C2(CCC3C4(C)CCC(O)CC4=CCC3C2C2)C)C2OC11CCC(C)CO1 WQLVFSAGQJTQCK-UHFFFAOYSA-N 0.000 description 1
- FPAFDBFIGPHWGO-UHFFFAOYSA-N dioxosilane;oxomagnesium;hydrate Chemical compound O.[Mg]=O.[Mg]=O.[Mg]=O.O=[Si]=O.O=[Si]=O.O=[Si]=O.O=[Si]=O FPAFDBFIGPHWGO-UHFFFAOYSA-N 0.000 description 1
- 238000009826 distribution Methods 0.000 description 1
- 230000035619 diuresis Effects 0.000 description 1
- 230000000857 drug effect Effects 0.000 description 1
- 208000017574 dry cough Diseases 0.000 description 1
- 230000009977 dual effect Effects 0.000 description 1
- 201000006549 dyspepsia Diseases 0.000 description 1
- 235000013399 edible fruits Nutrition 0.000 description 1
- IVTMALDHFAHOGL-UHFFFAOYSA-N eriodictyol 7-O-rutinoside Natural products OC1C(O)C(O)C(C)OC1OCC1C(O)C(O)C(O)C(OC=2C=C3C(C(C(O)=C(O3)C=3C=C(O)C(O)=CC=3)=O)=C(O)C=2)O1 IVTMALDHFAHOGL-UHFFFAOYSA-N 0.000 description 1
- 201000005619 esophageal carcinoma Diseases 0.000 description 1
- 230000001815 facial effect Effects 0.000 description 1
- 206010016256 fatigue Diseases 0.000 description 1
- 239000000835 fiber Substances 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 229930182478 glucoside Natural products 0.000 description 1
- 239000008187 granular material Substances 0.000 description 1
- 229920000591 gum Polymers 0.000 description 1
- 231100000869 headache Toxicity 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 206010019847 hepatosplenomegaly Diseases 0.000 description 1
- 210000001624 hip Anatomy 0.000 description 1
- 230000003054 hormonal effect Effects 0.000 description 1
- 239000001863 hydroxypropyl cellulose Substances 0.000 description 1
- 235000010977 hydroxypropyl cellulose Nutrition 0.000 description 1
- 229940071676 hydroxypropylcellulose Drugs 0.000 description 1
- 206010020718 hyperplasia Diseases 0.000 description 1
- 208000034783 hypoesthesia Diseases 0.000 description 1
- 201000001881 impotence Diseases 0.000 description 1
- 238000000338 in vitro Methods 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 208000014674 injury Diseases 0.000 description 1
- 238000011081 inoculation Methods 0.000 description 1
- 238000007689 inspection Methods 0.000 description 1
- 210000000936 intestine Anatomy 0.000 description 1
- 210000003127 knee Anatomy 0.000 description 1
- 210000000629 knee joint Anatomy 0.000 description 1
- 210000002429 large intestine Anatomy 0.000 description 1
- 210000000867 larynx Anatomy 0.000 description 1
- 230000002045 lasting effect Effects 0.000 description 1
- 210000002414 leg Anatomy 0.000 description 1
- 231100001252 long-term toxicity Toxicity 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 229940031703 low substituted hydroxypropyl cellulose Drugs 0.000 description 1
- 239000000314 lubricant Substances 0.000 description 1
- 201000005202 lung cancer Diseases 0.000 description 1
- 208000020816 lung neoplasm Diseases 0.000 description 1
- 210000001165 lymph node Anatomy 0.000 description 1
- 239000000594 mannitol Substances 0.000 description 1
- 235000010355 mannitol Nutrition 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 208000004396 mastitis Diseases 0.000 description 1
- 239000002398 materia medica Substances 0.000 description 1
- 229930014456 matrine Natural products 0.000 description 1
- 230000010534 mechanism of action Effects 0.000 description 1
- 235000010270 methyl p-hydroxybenzoate Nutrition 0.000 description 1
- 239000004292 methyl p-hydroxybenzoate Substances 0.000 description 1
- LXCFILQKKLGQFO-UHFFFAOYSA-N methylparaben Chemical compound COC(=O)C1=CC=C(O)C=C1 LXCFILQKKLGQFO-UHFFFAOYSA-N 0.000 description 1
- 201000002266 mite infestation Diseases 0.000 description 1
- 229960005181 morphine Drugs 0.000 description 1
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 description 1
- OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 description 1
- 244000052769 pathogen Species 0.000 description 1
- 210000003516 pericardium Anatomy 0.000 description 1
- 210000003024 peritoneal macrophage Anatomy 0.000 description 1
- 239000000546 pharmaceutical excipient Substances 0.000 description 1
- 229940124531 pharmaceutical excipient Drugs 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- 102000020233 phosphotransferase Human genes 0.000 description 1
- 229940012957 plasmin Drugs 0.000 description 1
- 231100000614 poison Toxicity 0.000 description 1
- 230000007096 poisonous effect Effects 0.000 description 1
- 230000002980 postoperative effect Effects 0.000 description 1
- 229920001592 potato starch Polymers 0.000 description 1
- 235000010232 propyl p-hydroxybenzoate Nutrition 0.000 description 1
- 239000004405 propyl p-hydroxybenzoate Substances 0.000 description 1
- 229960003415 propylparaben Drugs 0.000 description 1
- 208000008128 pulmonary tuberculosis Diseases 0.000 description 1
- FDRQPMVGJOQVTL-UHFFFAOYSA-N quercetin rutinoside Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC=2C(C3=C(O)C=C(O)C=C3OC=2C=2C=C(O)C(O)=CC=2)=O)O1 FDRQPMVGJOQVTL-UHFFFAOYSA-N 0.000 description 1
- 230000005855 radiation Effects 0.000 description 1
- 239000002516 radical scavenger Substances 0.000 description 1
- 238000011127 radiochemotherapy Methods 0.000 description 1
- 230000004223 radioprotective effect Effects 0.000 description 1
- 229940016667 resveratrol Drugs 0.000 description 1
- 235000021283 resveratrol Nutrition 0.000 description 1
- IKGXIBQEEMLURG-BKUODXTLSA-N rutin Chemical compound O[C@H]1[C@H](O)[C@@H](O)[C@H](C)O[C@@H]1OC[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](OC=2C(C3=C(O)C=C(O)C=C3OC=2C=2C=C(O)C(O)=CC=2)=O)O1 IKGXIBQEEMLURG-BKUODXTLSA-N 0.000 description 1
- ALABRVAAKCSLSC-UHFFFAOYSA-N rutin Natural products CC1OC(OCC2OC(O)C(O)C(O)C2O)C(O)C(O)C1OC3=C(Oc4cc(O)cc(O)c4C3=O)c5ccc(O)c(O)c5 ALABRVAAKCSLSC-UHFFFAOYSA-N 0.000 description 1
- 235000005493 rutin Nutrition 0.000 description 1
- 229960004555 rutoside Drugs 0.000 description 1
- 201000005113 shigellosis Diseases 0.000 description 1
- 239000000741 silica gel Substances 0.000 description 1
- 229910002027 silica gel Inorganic materials 0.000 description 1
- 230000004622 sleep time Effects 0.000 description 1
- 239000002002 slurry Substances 0.000 description 1
- 210000000813 small intestine Anatomy 0.000 description 1
- 230000002269 spontaneous effect Effects 0.000 description 1
- 239000008117 stearic acid Substances 0.000 description 1
- 150000003431 steroids Chemical class 0.000 description 1
- 201000000498 stomach carcinoma Diseases 0.000 description 1
- 229960005202 streptokinase Drugs 0.000 description 1
- 238000007920 subcutaneous administration Methods 0.000 description 1
- 230000001629 suppression Effects 0.000 description 1
- 230000002194 synthesizing effect Effects 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- 231100000886 tinnitus Toxicity 0.000 description 1
- 230000007306 turnover Effects 0.000 description 1
- 230000008728 vascular permeability Effects 0.000 description 1
- 231100000889 vertigo Toxicity 0.000 description 1
- 230000004304 visual acuity Effects 0.000 description 1
- 238000005303 weighing Methods 0.000 description 1
- 239000000080 wetting agent Substances 0.000 description 1
- RIPYIJVYDYCPKW-UOGIXDCTSA-N x1071 Chemical compound O([C@H]1[C@]2(O)C[C@H]3[C@@]45C6[C@@H]([C@@]([C@H]31)(OC(C)=O)[C@@H](O)[C@@H]2OC)[C@H](OC)[C@@H]4[C@]([C@@H](C[C@@H]5OC)OC(C)=O)(COC)CN6CC)C(=O)C1=CC=CC=C1 RIPYIJVYDYCPKW-UOGIXDCTSA-N 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/56—Materials from animals other than mammals
- A61K35/62—Leeches; Worms, e.g. cestodes, tapeworms, nematodes, roundworms, earth worms, ascarids, filarias, hookworms, trichinella or taenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/56—Materials from animals other than mammals
- A61K35/612—Crustaceans, e.g. crabs, lobsters, shrimps, krill or crayfish; Barnacles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/56—Materials from animals other than mammals
- A61K35/63—Arthropods
- A61K35/648—Myriapods, e.g. centipedes or millipedes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/16—Ginkgophyta, e.g. Ginkgoaceae (Ginkgo family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/24—Apocynaceae (Dogbane family), e.g. plumeria or periwinkle
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/25—Araliaceae (Ginseng family), e.g. ivy, aralia, schefflera or tetrapanax
- A61K36/254—Acanthopanax or Eleutherococcus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/35—Caprifoliaceae (Honeysuckle family)
- A61K36/355—Lonicera (honeysuckle)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/36—Caryophyllaceae (Pink family), e.g. babysbreath or soapwort
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/39—Convolvulaceae (Morning-glory family), e.g. bindweed
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/42—Cucurbitaceae (Cucumber family)
- A61K36/424—Gynostemma
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/481—Astragalus (milkvetch)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/489—Sophora, e.g. necklacepod or mamani
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
- A61K36/536—Prunella or Brunella (selfheal)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/70—Polygonaceae (Buckwheat family), e.g. spineflower or dock
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/70—Polygonaceae (Buckwheat family), e.g. spineflower or dock
- A61K36/704—Polygonum, e.g. knotweed
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/71—Ranunculaceae (Buttercup family), e.g. larkspur, hepatica, hydrastis, columbine or goldenseal
- A61K36/714—Aconitum (monkshood)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/73—Rosaceae (Rose family), e.g. strawberry, chokeberry, blackberry, pear or firethorn
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/73—Rosaceae (Rose family), e.g. strawberry, chokeberry, blackberry, pear or firethorn
- A61K36/736—Prunus, e.g. plum, cherry, peach, apricot or almond
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/74—Rubiaceae (Madder family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/894—Dioscoreaceae (Yam family)
- A61K36/8945—Dioscorea, e.g. yam, Chinese yam or water yam
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/896—Liliaceae (Lily family), e.g. daylily, plantain lily, Hyacinth or narcissus
- A61K36/8965—Asparagus, e.g. garden asparagus or asparagus fern
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/898—Orchidaceae (Orchid family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/33—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
- A61K2236/331—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones using water, e.g. cold water, infusion, tea, steam distillation or decoction
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/39—Complex extraction schemes, e.g. fractionation or repeated extraction steps
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Alternative & Traditional Medicine (AREA)
- Biotechnology (AREA)
- Botany (AREA)
- Medical Informatics (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Insects & Arthropods (AREA)
- Tropical Medicine & Parasitology (AREA)
- Marine Sciences & Fisheries (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
The invention relates to traditional Chinese medicine for treating tumors and a preparation method of traditional Chinese medicine. The traditional Chinese medicine comprises plant raw materials and animal raw materials by weight, wherein the plant raw materials are 22 to 35 parts of peach kernel, 12 to 20 parts of acanthopanax senticosus, 15 to 19 parts of cremastra appendiculata, 10 to 15 parts of herba gynostemmatis pentaphylli, 20 to 30 parts of astragalus membranaceus, 32 to 36 parts of semen cuscutae, 12 to 18 parts of radix sophorae flavescentis, 5 to 15 parts of giant knotweed, 8 to 15 parts of juncus effusus, 20 to 30 parts of arenaria brevipetala, 23 to 28 parts of discolorous clinquefoil root, 30 to 34 parts of ginkgo leaves, 20 to 25 parts of aconitum szechnyianum gay, 30 to 36 parts of asparagus cochinchinensis, 28 to 35 parts of starjasmine stem, 8 to 15 parts of fructus polygoni orientalis, 3 to 13 parts of selfheal, 30 to 50 parts of honeysuckle stem, 10 to 18 parts of rhizoma dioscoreae nipponicae, and 8 to 10 parts of uncaria rhynchophylla; theanimal raw materials are 3 to 5 parts of lumbricus, 4 to 8 parts of sea crab shell, and 2 to 5 parts of centipede; the weight ratio of the plant raw materials to the animal raw materials is 1:(0.01 to 0.05). According to the characteristics of drug property compatibility, the traditional Chinese medicine has the advantages that under the condition of inhibiting growth of tumor cells, the organic immunity and resistibility can be improved; the phagocytic function of macrophage can be promoted; the content of white blood cells can be increased; the haematopoietic function of bone marrow is protected; the ill symptoms and signs of patients can be improved.
Description
Technical field
The present invention relates to a kind of Chinese medicine and its preparation method for the treatment of tumour, belong to chronic disease therapy field.
Background technology
Tumour (Tumor) is one of main disease of current harm humans health, is a kind of common disease of the histocyte allobiosis hyperplasia causing human body by multiple factor, and lung tumors divides innocent tumour and malignant tumour. Be there is huge demand space by current Global Medicine market in safe and effective antitumor drug. The most basic biological property of tumour is unregulated cell growth, finds the important topic that the antitumour drug that growth of tumour cell has targeted inhibition effect is medicament research and development person.
The means of current treatment tumour mainly comprise chemotherapy, radiotherapy and operative treatment. But a large amount of clinical treatments proves, organism normal cell is had detrimental effect by chemotherapy and radiation while killing tumor cell. Chinese medicine is antitumor has the advantages such as mechanism of action uniqueness, lasting medicine, Mutiple Targets, many approach, Antitumor test is wide, toxic side effect is little, for treatment tumour, there is huge potentiality and irreplaceable advantage, nowadays progressively occupied dominant position clinically.
In the antitumor drug having now found that, what come from plant accounts for 32.25%. Finding antitumor activity component from natural phant is current and the focus of antitumor drug research and development in one period from now on.
Summary of the invention
Technical problem to be solved by this invention is to provide a kind of Chinese medicine treating tumour, the method of excision in prior art that overcomes adds the misery of patient, hinder its vigour, expense is huge, by the method for chemotherapy or radiotherapy, while killing tumour cell, also red corpuscle and white corpuscle is injured, cause patient to suffer untold misery, and cure the symptoms, not the disease, it is very difficult to thoroughly remove the defect that tumour threatens.
The technical scheme that the present invention solves the problems of the technologies described above is as follows: a kind of Chinese medicine treating tumour, is made up of the plant material raw material of following weight part and animal material, and described plant material is made up of following raw material:
Described animal material is made up of following raw material:
Earthworm 3-5 part sea crab shell 4-8 part centipede 2-5 part
The part by weight of described plant material and described animal material is 1:0.01-0.05.
The invention has the beneficial effects as follows: select applicable herbal medicine and proportioning according to property of medicine compatible experiments in the present invention; there is benefiting qi and removing blood stasis, clearing heat and detoxicating effect; immunity of organism resistibility can be improved while the growth of inhibition tumor cell; promote the phagocytic function of scavenger cell; increase leucocyte content; protection hemopoietic function of bone marrow; improve patient's ill symptoms and sign; it is mainly used in the treatment of the tumours such as lung tumors, mammary cancer, cancer of the stomach; also can be used for the postoperative adjuvant therapy of above-mentioned cancer; antitumor action is obvious, safe without toxic side effect curative effect.
On the basis of technique scheme, the present invention can also do following improvement.
The present invention is a kind of Chinese medicine treating tumour as mentioned above, and further, described gynostemma pentaphylla is 12-14 part.
The present invention is a kind of Chinese medicine treating tumour as mentioned above, further, and described Japanese Honeysuckle Stem 35-40 part.
The present invention is a kind of Chinese medicine treating tumour as mentioned above, further, and 30 parts, described peach kernel.
The present invention is a kind of Chinese medicine treating tumour as mentioned above, further, is made up of the raw material of following weight part:
Described animal material is made up of following raw material:
Earthworm 3-5 part sea crab shell 4-8 part centipede 2-5 part
The part by weight of described plant material and described animal material is 1:0.02-0.04.
The present invention is a kind of Chinese medicine treating tumour as mentioned above, further, is made up of the raw material of following weight part:
Described animal material is made up of following raw material:
Earthworm 3-5 part sea crab shell 4-8 part centipede 2-5 part
The part by weight of described plant material and described animal material is 1:0.03.
The present invention also provides the preparation method of a kind of Chinese medicine treating tumour, step 1) take plant material according to described part by weight and animal material mixes respectively, the blends of plant materials obtained, according to ratio boiling 2-3 hour of 1g:20-30ml water, filters; The dregs of a decoction add 3��and 5 times of quality water again decoct and boil 20��40min, filter; Merge twice fried liquid, fluid is concentrated to relative density be the medicinal extract of 1.05-1.12;
Step 2) described part by weight takes animal material, the animal material mixture obtained is elementary pulverized 60��100 order sieves, again micronizing to particle diameter at 5��50 �� m, according to part by weight and step 1 after sterilizing) medicinal extract mixes acquisition activeconstituents.
Activeconstituents, as effective ingredient, adds auxiliary material and makes tablet or capsule.
In the present invention, pharmaceutical excipient used, can be selected from tackiness agent (can be polyvidone, starch slurry, Mierocrystalline cellulose etc.), disintegrating agent (can be dry starch, Xylo-Mucine, low-substituted hydroxypropyl cellulose, PVP etc.), lubricant (can be talcum powder, stearic acid, calcium stearate magnesium, calcium stearate etc.), correctives (can be sucrose, A Siba is sweet, Steviosin, fructose etc.), stablizer (can be methyl p-hydroxybenzoate, propylparaben etc.), thinner (can be starch, dextrin, Icing Sugar, lactose etc.), wetting agent (can be water or ethanol), glidant (can be micropowder silica gel), vehicle (can be that carbohydrate derivative is such as lactose, sucrose, glucose, N.F,USP MANNITOL, sorbyl alcohol, starch based derivative is such as W-Gum, potato starch, dextrin or carboxymethyl starch, derivatived cellulose is such as crystalline fibers, hydroxy propyl cellulose, carboxymethyl cellulose.
Described anti-tumor Chinese medicine is in the application prepared in antitumor drug.
Described anti-tumor Chinese medicine is the medicine of short apoptosis of tumor cells.
Described antitumor drug comprises the medicine of adenocarcinoma of lung, the medicine of anti-cervical cancer, the medicine of anti-myeloma.
The pharmaceutical characteristic of each bulk drug of the present invention is as follows:
Above-mentioned all medicine compatibilities, there is positive QI-insufficiency in tumour patient, weakness of the spleen and the stomach, ecchymosis is tied pathogenic characteristic mutually and established;
Peach kernel: peach kernel bitter is sweet and property is put down, and can enter the heart, liver, large intestine, promoting blood circulation to remove blood stasis effect is very wide, available controls the various worn-out disease of stagnation of blood stasis.
Radix Et Caulis Acanthopanacis Senticosi: taste is pungent; Bitter; Micro-sweet; Warm in nature, return Liver Channel; Kidney channel. Function: wind-damp dispelling; Invigorating the liver and kidney; Strengthening the bones and muscles; Invigorate blood circulation arteries and veins; There is vasodilation, improve big cerebral blood volume, blood pressure is had dual regulation. Simultaneously Radix Et Caulis Acanthopanacis Senticosi can also antifatigue, radioprotective, qi-restoratives weak, strengthen hemopoietic function of bone marrow, and there is work of invigorating blood circulation
Pseudobulbus Cremastrae Seu Pleiones: sweet, micro-pungent, cool. Return liver, the spleen channel, clearing heat and detoxicating, the carbuncle that disappears dissipating bind.
Gynostemma pentaphylla, taste is sweet, bitter, cold nature. Gui Jing: return lung channel, the spleen channel, kidney channel. Function: energy benefit gas, calms the nerves, falls blood pressure, clearing heat and detoxicating, cough-relieving apophlegmatic.
The Radix Astragali: the Radix Astragali has invigorating QI to consolidate the body surface resistance, diuresis holder poison, apocenosis, effect of expelling pus and promoting granulation. Weak for the deficiency of vital energy, anorexia and loose stool, sinking of QI of middle-JIAO, rushes down prolapse of the anus for a long time, uterine bleeding of having blood in stool, exterior deficiency spontaneous perspiration, and ulcer difficulty is burst, and bursts for a long time and does not hold back, and the deficiency of blood is sallow, and interior heat is quenched one's thirst. " herbal classic " is recorded: " main ulcer, loses sore for a long time, apocenosis pain relieving. Qi-restoratives, children's's all kinds of diseases and ailments. " " Japan hanako materia medica " record: " help gas to strengthen muscles and bones, put on flesh and enrich blood. ".
South Dodder Seed Chinese Dodder Seed: South Dodder Seed Chinese Dodder Seed again " Shennong Bencaojing " is listed in top grade return through: smell is pungent, sweet, flat nontoxic. [function with cure mainly]: tonifying kidney and benefiting sperm, nourishes the liver to improve visual acuity. The waist knee muscles and bones being applicable to deficiency of the liver and kindey is ached, and legs and feet are weak and feeble, impotence and seminal emission, crazy talk, frequent micturition, dripping urination, dizzy, blurring of vision, tinnitus are deaf and the disease such as women is with down, habitual abortion. Generally it is listed in top grade can taking for a long time. Take bright order for a long time to make light of one's life by commiting suicide and prolong life.
Kuh-seng: for hot dysentery, have blood in stool, jaundice renal shutdown, leucorrhea with red and white discharge, cloudy swollen pruritus vulvae, eczema, wet sore, skin pruritus, mange leprosy; Control trichomonal vaginitis outward. Matrine has the effect reducing Turnover of Mouse Peritoneal Macrophages suppression P815 tumor cell proliferation in vitro.
Giant knotweed: Rhizoma Polygoni Cuspidati extract has antipyretic effect. Resveratrol glucoside and vetanarcol and urethanum have synergy, can obviously extend mouse sleep time. Scald wound is had convergence, protects from infection and antiinflammation by giant knotweed decoction.
Medulla Junci: micro-cold; Sweet, light; The thoughts of returning home; Lung; Small intestine; Bladder warp. Effect relieving stranguria by diuresis; Clearing heart fire.
Herba arenariae kansuensis: sweet is bitter, cold in nature; Return liver, courage, kidney channel. Nourishing YIN and benefiting blood, invigorating function of kidney and strengthening bone. For dryness of the lung cough, jaundice, hemoptysis, deficiency of blood wandering arthritis, arthralgia and myalgia, dizziness due to the kidney deficiency, essential hypertension.
Herba Potentillae Discoloris: all herbal medicine, can antipyretic, detumescence, only dysentery, hemostasis.
Ginkgo Leaf: nature and flavor: sweet, bitter, puckery is flat. Gui Jing: the thoughts of returning home, lung channel. Have promoting blood circulation and removing blood stasis, remove obstruction in channels to relieve pain, hold back lung and relieving asthma, change turbid effect falling fat. Cure mainly: for obstruction of collaterals by blood stasis, Obstruction of qi in the chest and cardialgia, stroke hemiplegia, the deficiency syndrome of the lung is coughed and breathed heavily, hyperlipidaemia.
Radix aconiti szechenyiani: the total alkali in Radix aconiti szechenyiani extract has significant analgesic activity, its analgesia intensity is 43.7 times of morphine, and its main effectively analgesic composition is napelline, 3-acetylaconitine, deoxidation napelline etc.
Asparagus fern: sweet, bitter, cold. Return lung, kidney channel. Function cures mainly: nourishing YIN to relieve dryness, and clearing lung-heat is promoted the production of body fluid. For dryness of the lung dry cough, pertussis phlegm sticks, and dry throat is thirsty, the dry constipation of intestines.
Stem of confederate-jasmine: have and dispel rheumatism, removes obstruction in channels to relieve pain, clearing heat and cooling blood, and effect of detoxify and promote the subsdence of swelling, cures mainly dispelling wind and removing obstruction in the collateral, and cool blood is subsided a swelling. For beriberoid pyretic arthralgia, muscle arteries and veins contraction, soreness of waist and knee joint, larynx numbness, carbuncle swells, injury from falling down.
Princes-feather Fruit: meridian distribution of property and flavor: salty, micro-cold. 1. " not Lu ": " taste is salty, micro-cold, nontoxic. " 2. " the southern regions of the Yunnan Province book on Chinese herbal medicine ": " is cold in nature flat, bitter. " 3. " medicinal material data compilation ": " is pungent, nontoxic. " 4. " medicinal material ": " property is put down, and taste is sweet. " enter liver, stomach, spleen three warp. Having ruffian dissipating bind, clearing away heat to and alleviating pain function. For lump in the abdomen abdominal distension, hepatosplenomegaly, the tuberculosis of cervical lymph nodes, quenches one's thirst, stomachache.
Spica Prunellae, Spica Prunellae is cold in nature, taste hardship sweet, pungent, micro-, there is the effect letting out clearly irascibility, mass dissipating and swelling eliminating, clearing heat and detoxicating, expelling phlegm for arresting cough, cooling blood for hemostasis, under being applicable to lymphoid tuberculosis, thyrocele, acute mastitis, vertigo, facial hemiparalysis, arthralgia and myalgia, pulmonary tuberculosis, metrorrhagia, band, acute infection icterohepatitis and bacillary dysentery etc. Modern pharmacological research shows, Spica Prunellae has the effect reducing blood pressure, and energy vasodilation, contained by it, rutin has anti-inflammatory action, and can reduce vascular permeability, reduces fragility, reduces liver fat and resists the effect of cancer cells.
Japanese Honeysuckle Stem, taste sweetness and bitterness, cold nature, clearing heat and detoxicating, dredge wind and removing obstruction in channels. For warm disease heating, toxic-heat and blood stasis, carbuncle swell sore, beriberoid pyretic arthralgia, and redness and swelling of joints heat is bitterly.
Ningpo Yam Rhizome: medicinal plant, root stock is containing the important source material that diosgenin is synthesizing steroid hormonal medicaments; Property is put down, bitter; Return liver, lung channel; Among the people be used for controlling lumbago and skelalgia, muscles and bones numbness, wound, cough pant.
Yncaria stem with hooks: taste hardship sweet, micro-, cold nature; Return liver, pericardium warp; Matter heavily fortified point is dived and is fallen, and has the flat liver of heat-clearing, and effect of relievng spasm by subduing liver-wind, controls hypertension, has a dizzy spell, nervous headache.
Earthworm: Lumbrukinase has been developed patent medicine, easy administration, safety, can not as streptokinase, and the medicines such as urea kinases easily cause high plasmin mass formed by blood stasis to cause profuse bleeding. Anticancer research proves, the esophageal carcinoma is had restraining effect by earthworm, is used in conjunction the short term effect to lung cancer with chemotherapeutics and is better than simple chemotherapy.
Sea crab shell: taste is salty, cool in nature, relieving dyspepsia, promoting blood circulation and stopping pain, detoxify and promote the subsdence of swelling.
Centipede: pungent, temperature; Poisonous. Returning Liver Channel, breath wind antispastic, dispersing pathogen accumulation, removes obstruction in channels to relieve pain.
In the present invention, mainly through by plant material and animal material combination rational proportion, synergy, has antitumor, auxiliary tumor chemoradiotherapy and has good result for the treatment of.
Embodiment
Being described in conjunction with following principle and feature to the present invention, example, only for explaining the present invention, is not intended to limit the scope of the present invention.
Embodiment 1
A kind of Chinese medicine treating tumour of the present invention, is made up of following raw material:
Described animal material is made up of following raw material:
Earthworm 5 parts of sea crab shells, 8 parts of centipedes 5 parts
The part by weight of described plant material and described animal material is 1:0.01.
The preparation method of the Chinese medicine of above-mentioned treatment tumour, step 1) take plant material according to described part by weight and animal material mixes respectively, the blends of plant materials obtained, according to the ratio boiling 3 hours of 1g:20ml water, filters; The dregs of a decoction add 5 times quality water is again decocted and is boiled 40min, filters; Merge twice fried liquid, fluid is concentrated to relative density be the medicinal extract of 1.12;
Step 2) described part by weight takes animal material, the animal material mixture obtained is elementary pulverized 60 orders sieves, then micronizing to particle diameter at 50 �� m, according to part by weight and step 1 after sterilizing) medicinal extract mixes.
Embodiment 2
A kind of Chinese medicine treating tumour of the present invention, is made up of following raw material:
Described animal material is made up of following raw material:
Earthworm 3g sea crab shell 4g centipede 2g
The part by weight of described plant material and described animal material is 1:0.05.
The preparation method of the Chinese medicine of above-mentioned treatment tumour, step 1) take plant material according to described part by weight and animal material mixes respectively, the blends of plant materials obtained, according to the ratio boiling 3 hours of 1g:30ml water, filters; The dregs of a decoction add 3 times quality water is again decocted and is boiled 40min, filters; Merge twice fried liquid, fluid is concentrated to relative density be the medicinal extract of 1.05;
Step 2) described part by weight takes animal material, the animal material mixture obtained is elementary pulverized 60 orders sieves, then micronizing to particle diameter at 20 �� m, according to part by weight and step 1 after sterilizing) medicinal extract mixes.
Embodiment 3
A kind of Chinese medicine treating tumour of the present invention, is made up of following raw material:
Described animal material is made up of following raw material:
Earthworm 4g sea crab shell 8g centipede 5g
The part by weight of described plant material and described animal material is 1:0.04.
The preparation method of the Chinese medicine of above-mentioned treatment tumour, step 1) take plant material according to described part by weight and animal material mixes respectively, the blends of plant materials obtained, according to the ratio boiling 3 hours of 1g:30ml water, filters; The dregs of a decoction add 5 times quality water is again decocted and is boiled 40min, filters; Merge twice fried liquid, fluid is concentrated to relative density be the medicinal extract of 1.12;
Step 2) described part by weight takes animal material, the animal material mixture obtained is elementary pulverized 100 orders sieves, then micronizing to particle diameter at 5 �� m, according to part by weight and step 1 after sterilizing) medicinal extract mixes.
Embodiment 4
A kind of Chinese medicine treating tumour of the present invention, further, is made up of following raw material:
Described animal material is made up of following raw material:
Earthworm 3g sea crab shell 6g centipede 4g
The part by weight of described plant material and described animal material is 1:0.03.
The preparation method of the Chinese medicine of above-mentioned treatment tumour, step 1) take plant material according to described part by weight and animal material mixes respectively, the blends of plant materials obtained, according to the ratio boiling 3 hours of 1g:30ml water, filters; The dregs of a decoction add 5 times quality water is again decocted and is boiled 40min, filters; Merge twice fried liquid, fluid is concentrated to relative density be the medicinal extract of 1.12;
Step 2) described part by weight takes animal material, the animal material mixture obtained is elementary pulverized 100 orders sieves, then micronizing to particle diameter at 50 �� m, according to part by weight and step 1 after sterilizing) medicinal extract mixes.
Embodiment 5
A kind of Chinese medicine treating tumour of the present invention, is made up of following raw material:
Described animal material is made up of following raw material:
Earthworm 4 parts of sea crab shells, 6 parts of centipedes 3 parts
The part by weight of described plant material and described animal material is 1:0.03.
The preparation method of the Chinese medicine of above-mentioned treatment tumour, step 1) take plant material according to described part by weight and animal material mixes respectively, the blends of plant materials obtained, according to the ratio boiling 3 hours of 1g:30ml water, filters; The dregs of a decoction add 3 times quality water is again decocted and is boiled 40min, filters; Merge twice fried liquid, fluid is concentrated to relative density be the medicinal extract of 11.12;
Step 2) described part by weight takes animal material, the animal material mixture obtained is elementary pulverized 60 orders sieves, then micronizing to particle diameter at 30 �� m, according to part by weight and step 1 after sterilizing) medicinal extract mixes.
The present invention can also concentrate and add routine and make capsule edible auxiliary materials and make capsule or granule.
1, acute toxinology experiment
Experimental animal: ICR mouse 70, body weight 17-22g, male and female half and half. From medical college of Peking University laboratory;
1.1, animal grouping: adopting male and female Stochastic Equilibrium method of grouping respectively, be divided into 7 groups, often organize 10, wherein a group is blank group.
1.2, dosage is determined: metering is designed to: quite former medicine 100g/kg, quite former medicine 200/kg (clinical design dosage), quite former medicine 300/kg, quite former medicine 400/kg, quite former medicine 500/kg.
1.3, administration: disposable gastric infusion: fasting 3-5 hour before administration, fasting 1-2 hour after administration, water is can't help in fasting. Adopt administration in batches, negative control group, quite former medicine 100g/kg, the first of quite former medicine 150g/kg sells medicine wholesale, determine after administration that set dosage is suitable, then give quite former medicine 200g/kg, quite former medicine 300g/kg, quite former medicine 400g/kg, quite former medicine 500g/kg. Observing more than 7 days continuously after administration, every day, the upper and lower noon respectively observed once subsequently, observed 14 days continuously. Record every observation index table 1 in detail.
Table 1. administration amount and survival condition
| Group | In former medicine/kg | Quantity | Survival rate % |
| 1 | 10 | 100 | |
| 2 | 100 | 10 | 100 |
| 3 | 200 | 10 | 100 |
| 4 | 300 | 10 | 100 |
| 5 | 400 | 10 | 100 |
| 6 | 500 | 10 | 100 |
Conclusion: when tested material gastric infusion dosage in this test reaches in former medicine 500g/kg, death does not occur. Judging according to acute toxicity grading criteria, this test medicine can be considered nontoxic.
2, long term toxicity test
General 6��9 week age of rat. When test starts, weight differences should not exceed or lower than the 20% of this experimental animal mean body weight;
Test grouping: generally establish three dosage groups and a control group. Dosage is determined: metering is designed to: quite former medicine 100g/kg, quite former medicine 200g/kg (clinical design dosage), quite former medicine 300g/kg, quite former medicine 400g/kg, quite former medicine 500g/kg.
Repetitively administered: disposable gastric infusion: fasting 3��5 hours before administration, fasting 1��2 hour after administration, water is can't help in fasting. Adopt administration in batches, negative control group, quite former medicine 100g/kg, the first of quite former medicine 150g/kg sells medicine wholesale, determine after administration that set dosage is suitable, then give quite former medicine 200g/kg, quite former medicine 300g/kg, quite former medicine 400g/kg, quite former medicine 500g/kg. Successive administration stops medication after 6 months, observe more than 1 month sky continuously. Record every observation index table 2 in detail.
Table 2. long_term toxcity test-results
| Group | In former medicine/kg | Quantity | Survival rate % |
| 1 | 20 | 100 | |
| 2 | 100 | 20 | 100 |
| 3 | 200 | 20 | 100 |
| 4 | 300 | 20 | 100 |
| 5 | 400 | 20 | 100 |
| 6 | 500 | 20 | 100 |
3, to the embodiment of the present invention 3 antineoplastic evaluating drug effect of Chinese medicine composition
3.1, animal grouping and modeling
50 ICR mouse, female, 18-22g, is divided into 5 groups at random after weighing, and often organizes 10. It is respectively: blank group, positive controls, the high, medium and low dosage group of Chinese medicine composition of the present invention. Select the S180 sarcoma knurl kind of 7��10 days of well-grown, it is inoculated in right side of mice armpit subcutaneous, about 4.5��5 �� 106Cell/only;
3.2, test medicine
Tumor inoculation is after 24 hours, and except model group and blank group, all the other group mouse give corresponding medicine, as follows:
Positive controls: select ZhenQi capsule to be positive control drug.
The Chinese medicine high dosage for the treatment of tumour: quite former medicine 500g/kg;
Dosage in the Chinese medicine for the treatment of tumour: quite former medicine 300g/kg;
The Chinese medicine low dosage for the treatment of tumour: quite former medicine 100g/kg;
3.3, Testing index
During administration, every day measures body weight, within the 8th day, puts to death animal, claims knurl weight, calculate each group of average knurl weight, press formula and obtain tumor control rate and carry out X2Inspection.
3.4, result
Chinese medicine composition of the present invention is little on the body weight impact of S180 sarcoma mouse, but S180 sarcoma is had obvious restraining effect. Tumour inhibiting rate is 43.7-64.52%; The results are shown in Table 3. Result shows this Chinese medicine inventive composition, and tumor inhibition effect is obvious, compares with model group and has significant differences P < 0.01.
Table 3. present composition is to the tumor-inhibiting action result of S180 mouse
��Represent and compare P < 0.01 with model group
The foregoing is only the better embodiment of the present invention, not in order to limit the present invention, within the spirit and principles in the present invention all, any amendment of doing, equivalent replacement, improvement etc., all should be included within protection scope of the present invention.
Claims (10)
1. treat the Chinese medicine of tumour for one kind, it is characterised in that, it is made up of the plant material of following weight part and animal material; Described plant material is made up of following raw material:
Described animal material is made up of following raw material:
Earthworm 3-5 part sea crab shell 4-8 part centipede 2-5 part.
2. a kind of Chinese medicine treating tumour according to claim 1, it is characterised in that, the part by weight of described plant material and described animal material is 1:0.01-0.05.
3. a kind of Chinese medicine treating tumour according to claim 1, it is characterised in that, described gynostemma pentaphylla is 12-14 part.
4. a kind of Chinese medicine treating tumour according to claim 3, it is characterised in that, described Japanese Honeysuckle Stem 35-40 part.
5. a kind of Chinese medicine treating tumour according to claim 3, it is characterised in that, 30 parts, described peach kernel.
6. a kind of Chinese medicine treating tumour according to claim 1, it is characterised in that, it is made up of the raw material of following weight part, described plant material is made up of following raw material:
Described animal material is made up of following raw material:
Earthworm 3-5 part sea crab shell 4-8 part centipede 2-5 part.
7. a kind of Chinese medicine treating tumour according to claim 6, it is characterised in that, the part by weight of described plant material and described animal material is 1:0.02-0.04.
8. a kind of Chinese medicine treating tumour according to claim 1, it is characterised in that, it is made up of the raw material of following weight part, described plant material is made up of following raw material:
Described animal material is made up of following raw material:
Earthworm 3-5 part sea crab shell 4-8 part centipede 2-5 part.
9. a kind of Chinese medicine treating tumour according to claim 8, it is characterised in that, the part by weight of described plant material and described animal material is 1:0.03.
10. the preparation method of the Chinese medicine of the described treatment tumour of the arbitrary item of claim 1 to 9, it is characterized in that, step 1) take plant material according to described part by weight and animal material mixes respectively, the blends of plant materials obtained, according to ratio boiling 2-3 hour of 1g:20-30ml water, filters; The dregs of a decoction add 3��and 5 times of quality water again decoct and boil 20��40min, filter; Merge twice fried liquid, fluid is concentrated to relative density be the medicinal extract of 1.05-1.12;
Step 2) described part by weight takes animal material, the animal material mixture obtained is elementary pulverized 60��100 orders sieves, then micronizing to particle diameter at 5��50 �� m, according to part by weight and step 1 after sterilizing) medicinal extract mixes.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201610183374.0A CN105617007A (en) | 2016-03-28 | 2016-03-28 | Traditional Chinese medicine for treating tumors and preparation method of traditional Chinese medicine |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201610183374.0A CN105617007A (en) | 2016-03-28 | 2016-03-28 | Traditional Chinese medicine for treating tumors and preparation method of traditional Chinese medicine |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN105617007A true CN105617007A (en) | 2016-06-01 |
Family
ID=56032614
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201610183374.0A Pending CN105617007A (en) | 2016-03-28 | 2016-03-28 | Traditional Chinese medicine for treating tumors and preparation method of traditional Chinese medicine |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN105617007A (en) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN106491827A (en) * | 2016-12-09 | 2017-03-15 | 河池市技术开发中心 | A kind of Chinese medicine composition for treating colt diarrhoeal diseasess and preparation method thereof |
Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101972454A (en) * | 2010-11-03 | 2011-02-16 | 何玉伟 | Medicament for treating lymphoma |
| CN104825817A (en) * | 2015-05-15 | 2015-08-12 | 黑龙江中医药大学 | Traditional Chinese medicine preparation with antitumor effect |
-
2016
- 2016-03-28 CN CN201610183374.0A patent/CN105617007A/en active Pending
Patent Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101972454A (en) * | 2010-11-03 | 2011-02-16 | 何玉伟 | Medicament for treating lymphoma |
| CN104825817A (en) * | 2015-05-15 | 2015-08-12 | 黑龙江中医药大学 | Traditional Chinese medicine preparation with antitumor effect |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN106491827A (en) * | 2016-12-09 | 2017-03-15 | 河池市技术开发中心 | A kind of Chinese medicine composition for treating colt diarrhoeal diseasess and preparation method thereof |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN102078569B (en) | Traditional Chinese medicine preparation for treating liver cancer and preparation method thereof | |
| CN105169017A (en) | Traditional Chinese medicine for treating kidney stone and preparation method of traditional Chinese medicine | |
| CN102247479B (en) | Antitumor strong medicine and preparation method thereof | |
| CN105213974A (en) | One treats lymphadenomatous Chinese medicine composition and application thereof | |
| CN106728770B (en) | Traditional Chinese medicine composition for tonifying kidney and replenishing vital essence and preparation method thereof | |
| CN103417911B (en) | Traditional Chinese medicine composition for supporting chemo-treatment | |
| CN104784508B (en) | For improving the preparation method of the Chinese medicine preparation of malignant tumor patient immunologic function | |
| CN105617007A (en) | Traditional Chinese medicine for treating tumors and preparation method of traditional Chinese medicine | |
| CN103656048A (en) | Drug for treating cow mastitis and preparation method thereof | |
| CN103893700B (en) | A kind of Chinese medicine composition treating breast carcinoma | |
| CN103405589B (en) | Traditional Chinese medicine composition for treating cow mastitis and preparation method thereof | |
| CN105816813A (en) | Medicine composition for treating breast cancer and preparing method and application of medicine composition | |
| CN105106634A (en) | Traditional Chinese medicine preparation for treating acute appendicitis and application thereof | |
| CN104784509B (en) | For improving the Chinese medicine preparation of malignant tumor patient immunologic function | |
| CN104825817A (en) | Traditional Chinese medicine preparation with antitumor effect | |
| CN101028421B (en) | Chinese medicine for treating chronic kidney failure | |
| CN103989994A (en) | Pharmaceutical preparation for treating chronic urticaria | |
| CN111956759B (en) | Tibetan medicine composition for adjuvant treatment of lung cancer and preparation method thereof | |
| CN103285131B (en) | Chinese medicine lotion for treating mastitis | |
| CN106177391A (en) | A kind of pharmaceutical composition treating cancer and preparation method thereof | |
| CN106074960A (en) | A kind of Chinese medicine composition treating breast carcinoma and cyclomastopathy and preparation method thereof | |
| CN105582379A (en) | Traditional Chinese medicine composition for treating liver-stomach disharmony and preparation method of traditional Chinese medicine composition | |
| CN104784608B (en) | Improve the preparation method of the medicine of toxicity after chemotherapy of tumors | |
| CN104800724B (en) | Improve the medicine of toxicity after chemotherapy of tumors | |
| CN104524149A (en) | Pharmaceutical composition for preventing and treating acute nephritis and application thereof |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| RJ01 | Rejection of invention patent application after publication |
Application publication date: 20160601 |
|
| RJ01 | Rejection of invention patent application after publication |